Willmar Schwabe India Aethusa Cynapium 1X (Q) (30ml) | Relief from Mental Weakness and Digestive Disturbances in Children
Willmar Schwabe India Aethusa Cynapium 1X (Mother Tincture) is prepared from the Aethusa Cynapium plant. It is a potent homeopathic remedy primarily used to address mental weakness, particularly in children, associated with gastrointestinal disturbances such as milk intolerance and vomiting. It also helps relieve restlessness, anxiety, and digestive issues like diarrhea and cramping pain after milk consumption.
Use of Willmar Schwabe India Aethusa Cynapium 1X (Q):
- Eases mental confusion, weakness, and inability to focus, especially in children
- Helps manage vomiting of curdled milk and gastrointestinal discomfort
- Reduces restlessness, anxiety, and crying in children
- Supports relief from diarrhea and cramping pain after milk intake
- Helps soothe exhaustion and weakness caused by vomiting and diarrhea
Key Ingredient
Aethusa Cynapium (Mother Tincture) – A well-known homeopathic remedy for addressing mental weakness, digestive disturbances, and restlessness in children.
Key Benefits
- Alleviates mental confusion, restlessness, and weakness in children
- Relieves vomiting of curdled milk and eases abdominal discomfort
- Supports emotional balance and reduces crying and anxiety
- Helps in reducing digestive complaints like diarrhea after milk
- Eases exhaustion caused by vomiting and diarrhea
Directions for Use
Take 10 drops in half a cup of water three times a day, or as directed by a homeopathic physician.
Safety Information
- Maintain a gap of at least 15 minutes before or after meals when taking the medicine
- Store in a cool, dry place away from direct sunlight
- Pregnant or lactating women should consult a healthcare practitioner before use
- Avoid tobacco, alcohol, and strong-smelling substances during medication
- Keep out of reach of children
Note
Willmar Schwabe India Aethusa Cynapium 1X provides gentle, holistic relief from mental and digestive disturbances in children. For optimal results, use under medical supervision based on symptom similarity.
